Comparative efficacy, safety, and functional recovery of neonatal fc receptor inhibitors and conventional immunotherapies for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and network meta-analysis. [PDF]
Front ImmunolJiang Q, Gu Z.
europepmc +1 more source
A Functional Investigation of Antibody Fc-FcRn Variant Binding Guided by In Silico Free Energy Perturbation Methods. [PDF]
J Mol BiolSampson JM +11 more
europepmc +1 more source
Comparative Characterisation of Five Plasma-Derived Human Serum Albumin Preparations: Structural Integrity, Functional Properties, and Quality Attributes. [PDF]
Pharmaceuticals (Basel)Farhane Z +6 more
europepmc +1 more source
Pathogenic properties of myasthenia gravis AChR autoantibodies associate with clinical response to efgartigimod. [PDF]
J Neurol Neurosurg PsychiatryKhani-Habibabadi F +10 more
europepmc +1 more source
B Cells and B Cell Depletion in Autoimmunity and Atherosclerosis. [PDF]
Life (Basel)Solomon JL +6 more
europepmc +1 more source
Clinical Course After a Single Cycle of Rozanolixizumab in Generalized Late-Onset Myasthenia Gravis. [PDF]
J Clin NeurolAritake S, Nagai A.
europepmc +1 more source
Targeted FcRn to deliver epitope-optimized RBD confers broad-spectrum mucosal protection against SARS-CoV-2. [PDF]
Mol Ther Nucleic AcidsChen X +12 more
europepmc +1 more source
Recaticimab: The First Fc-Engineered PCSK9 Monoclonal Antibody for More Long-Lasting Effect in Lipid Lowering. [PDF]
DrugsLi S, Gao Y, Zhu CG, Li JJ.
europepmc +1 more source
Antibody-Based Therapeutics in Autoimmune Diseases: Mechanisms, Challenges, and Future Perspectives. [PDF]
Int J Mol SciMahroum N.
europepmc +1 more source
Human Pharmacokinetic Prediction of Antibody-Drug Conjugates Using Human FcRn Transgenic Mice. [PDF]
Clin Transl SciNakagawa K, Haraya K.
europepmc +1 more source